Associated Press: Biosion Announces First Patient Dosed in Investigator-Initiated Phase 1 Trial of BSI-082
February 6, 2026
Associated Press: Biosion Announces First Patient Dosed in Investigator-Initiated Phase 1 Trial of BSI-082
yahoo! news: Biosion doses first patient in phase Ia/Ib BSI-082 trial for solid tumours
February 6, 2026
John Sarantopoulos, MD, associate professor, Department of Medicine, Division of Hematology and Oncology, and medical oncologist, Mays Cancer Center, was mentioned in this article. Read More
MSN.com: Biosion doses first patient in phase Ia/Ib BSI-082 trial for solid tumours
February 6, 2026
MSN.com: Biosion doses first patient in phase Ia/Ib BSI-082 trial for solid tumours
MedPage Today: GLP-1 Use Linked to Lower Colon Cancer Risk vs Aspirin
January 7, 2026
MadePage Today: GLP-1 Use Linked to Lower Colon Cancer Risk vs Aspirin
U.S. News & World Report: Ozempic, Wegovy Might Lower Colon Cancer Risk
January 7, 2026
U.S. News & World Report: Ozempic, Wegovy Might Lower Colon Cancer Risk
UT Health San Antonio awarded $3 million CPRIT grant to bolster cancer research and prevention efforts in South Texas
December 12, 2025
UT Health San Antonio received nearly $3 million in new academic and prevention awards as part of the latest, almost $154 million funding round announced on Nov. 19 by the Cancer Prevention Research Institute of Texas (CPRIT).
